Most Recent
A judge has ordered Fortrend Securities to pay $181,000 in penalties after finding it unlawfully withheld the bonuses of two financial advisers who jumped ship to rival Shaw & Partners, saying the lower penalties were appropriate despite "not a word of contrition”.
Construction PRO
Clive Palmer's Mineralogy can access the content of email inboxes of two senior executives at engineering firm CITIC in a feud over the $12 billion Sino Iron project in Western Australia’s Pilbara region.
Dovetail has hit back at a lawsuit alleging its boss sexually assaulted the tech start-up’s female legal counsel, claiming it was a “consensual loving relationship”.
Construction PRO
A court has clarified that BaptistCare Community Housing can use a social housing property in Five Dock to secure a loan from Housing Australia for improvements at the site.
A judge has said Sydney firm Atanskovic Hartnell’s garnishee order was “entirely unacceptable” in a long-running fee fight with its former client, a company owned by media mogul Bruce Gordon.
Construction PRO
Lender WholeCap has lost its bid for a “break fee” and $430,000 in legal costs billed by King & Wood Mallesons associated with a term sheet for a proposed $66.1 million loan to a Harbour Land entity.
Seven has gone on the offensive in a lawsuit by former Spotlight producer Taylor Auerbach that alleges the broadcaster breached a settlement deed and defamed him, arguing it was Auerbach who broke the terms of their agreement.
Construction PRO
King & Wood Mallesons has advised Transgrid on a project to connect the country's first renewable energy zone to NSW's energy grid.
Construction PRO
A contractor working on upgrades at the Metropolitan Remand Centre in Victoria has filed proceedings against the Victorian Correction Infrastructure Partnership, arguing a dispute resolution clause in their contract runs afoul of the SOP Act.
Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.